Product Information
DRONABINOL 5 MG CAPSULE is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $3.3535 per EA under NDC 42858086806. Its NADAC has been published 380 times since Nov 14, 2018.
FDA first approved this application on Jun 27, 2008.
Strength
5 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858086806
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DRONABINOLApproval Type
Generic (ANDA)
FDA Application
ANDA078292FDA Approved
6/27/2008
On Market Since
6/26/2018
Pharmacological Classes
Price Statistics
The NADAC for DRONABINOL 5 MG CAPSULE has been published 380 times since Nov 14, 2018, and over the history we have for it it has declined 12.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3535 per EA |
|---|---|
| All-time high | $4.0896 (Feb 13, 2019) |
| All-time low | $1.8485 (Jun 21, 2023) |
| 52-week high | $3.3535 |
| 52-week low | $2.9465 |
| Median price | $2.6279 |
| Average price | $2.7156 |
| Largest weekly change | +43.4% (Oct 18, 2023) |
| Weeks tracked | 380 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rhodes Pharmaceuticals L.P. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DRONABINOL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cannabinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DRONABINOL 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DRONABINOL 5 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $3.3535 per EA (NDC 42858086806), effective Sep 30, 2026.
How has the price of DRONABINOL 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DRONABINOL 5 MG CAPSULE has declined 12.5%. It has been tracked across 380 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for DRONABINOL 5 MG CAPSULE?
Since Nov 14, 2018, the NADAC for DRONABINOL 5 MG CAPSULE has ranged from a low of $1.8485 (Jun 21, 2023) to a high of $4.0896 (Feb 13, 2019), with a median of $2.6279 per EA.
Are there cheaper alternatives to DRONABINOL 5 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DRONABINOL 5 MG CAPSULE, is $2.9465 per EA — about 12% below DRONABINOL 5 MG CAPSULE.
Who manufactures DRONABINOL 5 MG CAPSULE?
DRONABINOL 5 MG CAPSULE (NDC 42858086806) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.